Companies
Exyte
Industry giants like Exyte leverage modular frameworks (e.g., ExyCell) to deliver complete, turnkey biomanufacturing facilities globally.
- Country
- Germany
Commercial
ExyCell
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| cleanroom-facilities | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaema
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | Private equity investment led by BDT & MSD Partners (2022-11-16) | exyte.net |
| Capacity | Includes 1,600 m2 of cleanroom space at the WACKER mRNA competence center in Halle, Germany | exyte.net |
| Certification | cGMP and GMP compliant designs and solutions | exyte.net |
| Regulatory approval | ExyCell modular designs engineered for regulatory compliance including cGMP standards | exyte.net |
| Production site | Facilities and offices across 51 countries, including Germany (e.g., Halle, Stuttgart), USA, Singapore, Ireland, and others | exyte.net · prnewswire.com |
| Headcount | Approximately 9,740 employees worldwide as of 2023 | exyte.net · prnewswire.com · scribd.com |
| Revenue | €7.1 billion in 2023 | exyte.net · prnewswire.com · scribd.com |
Independent sources: prnewswire.com · scribd.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Modular / mobile cleanrooms | cleanroom-facilities | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.